Unknown

Dataset Information

0

A Systematic Review and Meta-Analysis of Front-line Anthracycline-Based Chemotherapy Regimens for Peripheral T-Cell Lymphoma.


ABSTRACT: Anthracycline-based chemotherapy remains standard treatment for peripheral T-cell lymphoma (PTCL) although its benefits have been questioned. We performed systematic literature review and meta-analyses examining the complete response (CR) and overall survival (OS) rates for patients with PTCL. The CR rate for PTCL patients ranged from 35.9% (95% CI 23.4-50.7%) for enteropathy-type T-cell lymphoma (ETTL) to 65.8% (95% CI 54.0-75.9%) for anaplastic large cell lymphoma (ALCL). The 5-year OS was 38.5% (95% CI 35.5-41.6%) for all PTCL patients and ranged from 20.3% (95% CI 12.5-31.2%) for ETTL to 56.5% (95% CI 42.8-69.2%) for ALCL. These data suggest that there is marked heterogeneity across PTCL subtypes in the benefits of anthracycline-based chemotherapy. While anthracyclines produce CR in half of PTCL patients, this yields reasonable 5-year OS for patients with ALCL but not for those with PTCL-NOS or ETTL. Novel agents and regimens are needed to improve outcomes for these patients.

SUBMITTER: Abouyabis AN 

PROVIDER: S-EPMC3197255 | biostudies-other | 2011

REPOSITORIES: biostudies-other

altmetric image

Publications

A Systematic Review and Meta-Analysis of Front-line Anthracycline-Based Chemotherapy Regimens for Peripheral T-Cell Lymphoma.

Abouyabis Abeer N AN   Shenoy Pareen J PJ   Sinha Rajni R   Flowers Christopher R CR   Lechowicz Mary Jo MJ  

ISRN hematology 20110616


Anthracycline-based chemotherapy remains standard treatment for peripheral T-cell lymphoma (PTCL) although its benefits have been questioned. We performed systematic literature review and meta-analyses examining the complete response (CR) and overall survival (OS) rates for patients with PTCL. The CR rate for PTCL patients ranged from 35.9% (95% CI 23.4-50.7%) for enteropathy-type T-cell lymphoma (ETTL) to 65.8% (95% CI 54.0-75.9%) for anaplastic large cell lymphoma (ALCL). The 5-year OS was 38.  ...[more]

Similar Datasets

| S-EPMC4042304 | biostudies-literature
| S-EPMC10485051 | biostudies-literature
| S-EPMC2394229 | biostudies-other
| S-EPMC4097092 | biostudies-literature
| S-EPMC9295862 | biostudies-literature
| S-EPMC6825156 | biostudies-literature
| S-EPMC5053427 | biostudies-literature
| S-EPMC5478304 | biostudies-literature
| S-EPMC10515528 | biostudies-literature
| S-EPMC6020442 | biostudies-literature